These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6502929)

  • 21. [Clinical observation on the transport of cefotiam into the bile and gall bladder tissue].
    Tohyama K; Miyake T; Morinaga H; Futakuchi S; Izumi M; Yamanaka T; Egami H; Yamane T; Ga S; Fujishima K
    Jpn J Antibiot; 1983 Jun; 36(6):1439-42. PubMed ID: 6317904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amikacin levels in the human biliary tract.
    LeFrock JL; Schell RF; Siskind S; Carr BB
    J Clin Pharmacol; 1984; 24(5-6):247-54. PubMed ID: 6747021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fundamental and clinical studies on cefminox in the field of pediatrics].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Mar; 38(3):705-19. PubMed ID: 3897604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibiotic susceptibility of bacteria isolated from surgical infections (first report)].
    Yura J; Shinagawa N; Ishikawa S; Hayasaka H; Shiramatsu K; Ishibiki K; Aikawa N; Suzuki H; Takahashi T; Sakai K
    Jpn J Antibiot; 1986 Oct; 39(10):2557-78. PubMed ID: 3543430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentration of cefixime in bile, gallbladder wall and serum after preoperative administration in patients undergoing cholecystectomy.
    Moorthi K; Fleckenstein G; Nies B
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):287-90. PubMed ID: 2374476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of the liver and biliary tract to anaerobic infection in extrahepatic biliary tract obstruction. III. Possible synergistic effect between anaerobic and aerobic bacteria. An experimental study in rabbits.
    Lykkegaard Nielsen M; Asnaes S; Justesen T
    Scand J Gastroenterol; 1976; 11(3):263-72. PubMed ID: 775613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentrations of ciprofloxacin in human liver, gallbladder, and bile after oral administration.
    Dan M; Verbin N; Gorea A; Nagar H; Berger SA
    Eur J Clin Pharmacol; 1987; 32(2):217-8. PubMed ID: 3582488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on tissue concentrations of cefoperazone and piperacillin classified by the site of the wall of gallbladder and concentration of piperacillin in the bile after operation].
    Shima K; Ueno K; Ooto T; Shima Y; Miyata T; Sei T; Yonemura Y; Uemura T; Takano N
    Jpn J Antibiot; 1984 Jun; 37(6):966-72. PubMed ID: 6492387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)].
    Abe H; Hirasawa S; Bekki E; Sawada Y; Hashimoto I; Nakamura T; Mikami J; Katoh H; Matsuda S
    Jpn J Antibiot; 1981 Apr; 34(4):631-40. PubMed ID: 6457172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of the liver and biliary tract to anaerobic infection in extrahepatic biliary tract obstruction. Bacteriological investigations - an experimental study in rabbits.
    Nielsen ML; Justesen T
    Scand J Gastroenterol; 1975; 10(7):769-75. PubMed ID: 1188311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemotherapy of biliary tract infections. XIV. Biliary excretion and gallbladder tissue levels of piperacillin (author's transl)].
    Tanimura H; Saito T; Sekiya T; Kobayashi N; Hikasa Y
    Jpn J Antibiot; 1981 Oct; 34(10):1401-9. PubMed ID: 6460883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biliary levels of ceforanide.
    Kenady DE; Ram MD
    Antimicrob Agents Chemother; 1983 May; 23(5):706-9. PubMed ID: 6870219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fundamental and clinical evaluation on ceftriaxone in the pediatric field].
    Toyonaga Y; Kurosu Y; Uekusa T; Nakamura H; Sugita M; Okabe T; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1984 Nov; 37(11):2060-82. PubMed ID: 6098702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatobiliary kinetics and excretion of ciprofloxacin.
    Parry MF; Smego DA; Digiovanni MA
    Antimicrob Agents Chemother; 1988 Jul; 32(7):982-5. PubMed ID: 3190199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of bile diffusion of piperacillin].
    Brogard JM; Jehl F; Paris-Bockel D; Blickle JF; Arnaud JP; Monteil H
    Presse Med; 1986 Dec; 15(46):2332-5. PubMed ID: 2949279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study on the penetration of cefmenoxime into bile and gallbladder tissues and the pathological changes of inflamed tissues].
    Tsuburaya H; Ando Y; Kimizima I; Watanabe I; Abe R; Funayama T; Kawaguchi Y
    Jpn J Antibiot; 1986 Sep; 39(9):2381-5. PubMed ID: 3467080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental study of the biliary excretion of antibiotic (cefotiam) in the presence of biliary tract obstruction (author's transl)].
    Yoshikawa N; Tsuji Y; Sato Y; Ikeda Y; Shinada Y; Kawanishi N; Tamaki A; Kasai Y
    Jpn J Antibiot; 1979 Nov; 32(11):1101-6. PubMed ID: 513292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical effect of cefmenoxime on cholecystitis; its clinical efficacy and tissue concentration].
    Bekki E; Abe H; Sawada Y; Hashimoto I; Nakamura T; Mikami J; Kasai Y; Nakanishi M
    Jpn J Antibiot; 1983 Jul; 36(7):1604-14. PubMed ID: 6317907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.